Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSYIL 781 is an antagonist of the growth hormone secretagogue receptor 1a (GHS-R1a; Ki = 0.017 µM).1 It is selective for GHS-R1a over the motilin receptor (Ki = 6 µM) and a panel of 30 receptors and enzymes (Kis = >10 µM). YIL 781 (1 µM) prevents ghrelin-induced decreases in insulin secretion in glucose-stimulated isolated rat pancreatic islets. It increases plasma insulin levels and decreases blood glucose levels in an intraperitoneal glucose tolerance test in rats when administered at doses of 0.3 or 10 mg/kg, respectively. YIL 781 (10 and 20 mg/kg) inhibits cocaine-induced hyperlocomotion in mice.2
WARNING This product is not for human or veterinary use.
1. Small-
2. Ghrelin receptor antagonism of hyperlocomotion in cocaine-